Dougall William C相关文献与解析，生知库

Wunderle, Marius; Heindl, Felix; Behrens, Annika S; Häberle, Lothar; Hack, Carolin C; Heusinger, Katharina; Huebner, Hanna; Gass, Paul; Ruebner, Matthias; Schulz-Wendtland, Rüdiger; Erber, Ramona; Hartmann, Arndt; Beckmann, Matthias W; Dougall, William C; Press, Michael F; Fasching, Peter A; Emons, Julius

RAN

肿瘤

肿瘤免疫

乳腺癌

发表日期：2024

文献求助收藏

RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer

早期乳腺癌患者肿瘤中RANK和RANKL的表达

期刊:Geburtshilfe Und Frauenheilkunde

影响因子:1.9

doi:10.1055/a-2192-2998

Behrens, Annika; Wurmthaler, Lena; Heindl, Felix; Gass, Paul; Häberle, Lothar; Volz, Bernhard; Hack, Carolin C; Emons, Julius; Erber, Ramona; Hartmann, Arndt; Beckmann, Matthias W; Ruebner, Matthias; Dougall, William C; Press, Michael F; Fasching, Peter A; Huebner, Hanna

NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages

NMDAR拮抗剂通过调节肿瘤相关巨噬细胞来抑制肿瘤进展。

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:9.1

doi:10.1073/pnas.2302126120

Yuan, Dongchen; Hu, Jing; Ju, Xiaoman; Putz, Eva Maria; Zheng, Simin; Koda, Stephane; Sun, Guowei; Deng, Xiaoran; Xu, Zhipeng; Nie, Wei; Zhao, Yang; Li, Xianyang; Dougall, William C; Shao, Simin; Chen, Yan; Tang, Renxian; Zheng, Kuiyang; Yan, Juming

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

CD155 缺失通过宿主和肿瘤内在机制的共同作用增强肿瘤抑制作用。

期刊:Journal of Clinical Investigation

影响因子:13.6

doi:10.1172/JCI159825

Li, Xian-Yang; Das, Indrajit; Lepletier, Ailin; Addala, Venkateswar; Bald, Tobias; Stannard, Kimberley; Barkauskas, Deborah; Liu, Jing; Aguilera, Amelia Roman; Takeda, Kazuyoshi; Braun, Matthias; Nakamura, Kyohei; Jacquelin, Sebastien; Lane, Steven W; Teng, Michele Wl; Dougall, William C; Smyth, Mark J

CD96 Is an Immune Checkpoint That Regulates CD8(+) T-cell Antitumor Function.

CD96 是一种免疫检查点，可调节 CD8(+) T 细胞的抗肿瘤功能

期刊:Cancer Immunology Research

影响因子:8.2

doi:10.1158/2326-6066.CIR-18-0637

Mittal Deepak, Lepletier Ailin, Madore Jason, Aguilera Amelia Roman, Stannard Kimberley, Blake Stephen J, Whitehall Vicki L J, Liu Cheng, Bettington Mark L, Takeda Kazuyoshi, Long Georgina V, Scolyer Richard A, Lan Ruth, Siemers Nathan, Korman Alan, Teng Michele W L, Johnston Robert J, Dougall William C, Smyth Mark J

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

非小细胞肺癌 (NSCLC) 术前 PD1 检查点阻断和 NFkB 受体激活剂配体 (RANKL) 抑制的药效学：一项多中心、开放标签、1B/2 期转化试验 (POPCORN) 的研究方案

期刊:Trials

影响因子:2

doi:10.1186/s13063-019-3951-x

Ahern, Elizabeth; Cubitt, Annette; Ballard, Emma; Teng, Michele W L; Dougall, William C; Smyth, Mark J; Godbolt, David; Naidoo, Rishendran; Goldrick, Amanda; Hughes, Brett G M

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

CD155 缺失通过宿主和肿瘤内在机制的共同作用增强肿瘤抑制作用。

期刊:Journal of Clinical Investigation

CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity

靶向CD96的抗体无需阻断CD96-CD155相互作用即可促进NK细胞的抗转移活性。

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2018.1424677

Roman Aguilera, Amelia; Lutzky, Viviana P; Mittal, Deepak; Li, Xian-Yang; Stannard, Kimberley; Takeda, Kazuyoshi; Bernhardt, Günter; Teng, Michele W L; Dougall, William C; Smyth, Mark J

RANK and RANK ligand expression in primary human osteosarcoma

RANK及其配体在原发性人类骨肉瘤中的表达

期刊:Journal of Bone Oncology

影响因子:3.5

doi:10.1016/j.jbo.2015.06.002

Branstetter, Daniel; Rohrbach, Kathy; Huang, Li-Ya; Soriano, Rosalia; Tometsko, Mark; Blake, Michelle; Jacob, Allison P; Dougall, William C

Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone

同时靶向骨形态发生蛋白通路和RANK/RANKL轴对骨溶解性前列腺癌病变的影响

期刊:

影响因子:

doi:10.1016/j.bone.2008.09.009

Virk, Mandeep S; Petrigliano, Frank A; Liu, Nancy Q; Chatziioannou, Arion F; Stout, David; Kang, Christine O; Dougall, William C; Lieberman, Jay R

Correlation of RANK and RANKL with mammographic density in primary breast cancer patients

RANK 和 RANKL 与原发性乳腺癌患者乳腺X线摄影密度的相关性

RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer

早期乳腺癌患者肿瘤中RANK和RANKL的表达

NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages

NMDAR拮抗剂通过调节肿瘤相关巨噬细胞来抑制肿瘤进展。

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

CD155 缺失通过宿主和肿瘤内在机制的共同作用增强肿瘤抑制作用。

CD96 Is an Immune Checkpoint That Regulates CD8(+) T-cell Antitumor Function.

CD96 是一种免疫检查点，可调节 CD8(+) T 细胞的抗肿瘤功能

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

非小细胞肺癌 (NSCLC) 术前 PD1 检查点阻断和 NFkB 受体激活剂配体 (RANKL) 抑制的药效学：一项多中心、开放标签、1B/2 期转化试验 (POPCORN) 的研究方案

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

CD155 缺失通过宿主和肿瘤内在机制的共同作用增强肿瘤抑制作用。

CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity

靶向CD96的抗体无需阻断CD96-CD155相互作用即可促进NK细胞的抗转移活性。

RANK and RANK ligand expression in primary human osteosarcoma

RANK及其配体在原发性人类骨肉瘤中的表达

Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone

同时靶向骨形态发生蛋白通路和RANK/RANKL轴对骨溶解性前列腺癌病变的影响